1. Home
  2. STOK vs KSS Comparison

STOK vs KSS Comparison

Compare STOK & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$36.13

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Kohl's Corporation

KSS

Kohl's Corporation

HOLD

Current Price

$16.31

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
KSS
Founded
2014
1962
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
STOK
KSS
Price
$36.13
$16.31
Analyst Decision
Strong Buy
Sell
Analyst Count
10
14
Target Price
$36.10
$15.83
AVG Volume (30 Days)
560.9K
3.1M
Earning Date
04-15-2026
01-01-0001
Dividend Yield
N/A
2.87%
EPS Growth
30.67
N/A
EPS
0.85
1.30
Revenue
$36,555,000.00
N/A
Revenue This Year
$430.19
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$42.08
$13.40
Revenue Growth
316.34
N/A
52 Week Low
$5.35
$6.04
52 Week High
$38.62
$25.22

Technical Indicators

Market Signals
Indicator
STOK
KSS
Relative Strength Index (RSI) 64.73 35.02
Support Level $30.50 $14.88
Resistance Level $37.98 $17.04
Average True Range (ATR) 2.04 1.06
MACD 0.41 -0.15
Stochastic Oscillator 77.87 3.17

Price Performance

Historical Comparison
STOK
KSS

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About KSS Kohl's Corporation

Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.

Share on Social Networks: